Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols

被引:20
|
作者
Anger, DL
Petre, MA
Crankshaw, DJ
机构
[1] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Honours Biol & Pharmacol Programme, Hamilton, ON, Canada
关键词
CYP1A1; tea; polyphenols; EROD; catechins; activation; (-)-epigallocatechin gallate;
D O I
10.1038/sj.bjp.0706255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We studied 7-ethoxyresorufin deethylase as an index of cytochrome P4501A1 (CYP1A1) activity in liver microsomes from rats pretreated with 3-methylcholanthrene. The enzyme had complex kinetics compatible with a multisite model. 2 At 1 mu m substrate, brewed black, green and white teas had complex effects on enzyme activity consisting of activation at low concentrations and inhibition at higher concentrations. 3 Data fit well to a two-site model that allowed us to determine maximal activation (% increase above control), pEC(50) for activation (g ml(-1)) and pIC(50) for inhibition (g ml(-1)). These parameters were 190 +/- 40, 5.9 +/- 0.1 and 4.51 +/- 0.09 for green tea, 350 +/- 40, 5.43 +/- 0.05 and 5.43 +/- 0.05 for black tea and 230 +/- 80, 5.3 +/- 0.3 and 4.7 +/- 0.2 for white tea, respectively. 4 The effects of the brewed teas were mimicked to different degrees by the green tea polyphenols. Maximal activation, pEC(50) (m) and pIC(50) (M) Were: (-)-epicatechin, 55 +/- 9, 5.4 +/- 0.3, 2 +/- 1; (-)-epicatechin gallate, 160 +/- 60, 6.2 +/- 0.3, 5.28 +/- 0.06; (-)-epigallocatechin 30 +/- 10, 6.5 +/- 0.5, 3.37 +/- 0.08; and (-)-epigallocatechin gallate 130 +/- 40, 6.7 +/- 0.3. 5.0 +/- 0.1. A crude extract of black tea polyphenols inhibited 7-ethoxyresorufin deethylase, but did not cause enzyme activation consistently. 5 Enzyme activation was dependent upon substrate concentration. 6 Heteroactivation of CYP1A1 may partially explain the lack of agreement between biological and epidemiological evidence of a role for tea in cancer prevention.
引用
收藏
页码:926 / 933
页数:8
相关论文
共 50 条
  • [21] Isolation and sequence analysis of the eel cytochrome P450 1A1 gene
    Aoki, J
    Itakura, T
    Kato, H
    Sato, M
    MARINE BIOTECHNOLOGY, 1999, 1 (04) : 371 - 375
  • [22] Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer
    Tsuchiya, Y
    Sato, T
    Kiyohara, C
    Yoshida, K
    Ogoshi, K
    Nakamura, K
    Yamamoto, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (01) : 119 - 124
  • [23] The effect of cytochrome b5 on a reaction cycle of cytochrome P450 1A1
    Indra, R.
    Milichovsky, J.
    Moserova, M.
    Arlt, V. M.
    Stiborova, M.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S286 - S286
  • [24] Effects of smoking on P-glycoprotein and cytochrome P450 1A1 in human placenta
    Kolwankar, DR
    Glover, DD
    Tracy, TS
    DRUG METABOLISM REVIEWS, 2002, 34 : 88 - 88
  • [25] Interactions among NADPH-cytochrome P450 reductase, P450 1A1, and P4502B4
    Backes, WL
    Cawley, GF
    FASEB JOURNAL, 1999, 13 (05): : A811 - A811
  • [26] Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain
    Morse, DC
    Stein, AP
    Thomas, PE
    Lowndes, HE
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 152 (01) : 232 - 239
  • [27] Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes
    Baumgart, A
    Schmidt, M
    Schmitz, HJ
    Schrenk, D
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) : 657 - 667
  • [28] Induction of cytochrome P450 1A1 by food derived heterocyclic aromatic amines
    Hümmerich, J
    Zohm, C
    Pfau, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R169 - R169
  • [29] Mechanism-based inhibition of human cytochrome p450 1A1 by rhapontigenin
    Chun, YJ
    Ryu, SY
    Jeong, TC
    Kim, MY
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (04) : 389 - 393
  • [30] Superinduction of oxidized tryptophan-inducible cytochrome P450 1a1 by cycloheximide
    Sindhu, RK
    Yan, RZ
    Kikkawa, Y
    FASEB JOURNAL, 1997, 11 (09): : A821 - A821